Concerta
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Treatment effectiveness between equivalent doses of non-OROS (osmotic controlled release oral delivery system) methylphenidate ER…
To the Editor:
Attention-deficit hyperactivity disorder (ADHD) is one of the most common conditions of childhood1, 2 and is…
Objective: The main aim of this study was to examine the efficacy, tolerability, and compliance of an extended-release…
A 14-year-old girl with suicidal ideation was presented to the paediatric hospital about 2 h after ingestion of 21 long-acting…
Attention-deficit/hyperactivity disorder may have substantial impact on family life, peer interactions, and quality of life…
AbstractBackground: The potential advantages of osmotic-release oral system (OROS) methylphenidate (Concerta®) over immediate…
AimThe aim of this study was to assess the impact of switching from immediate-release (IR) methylphenidate (MPH) to OROS® MPH…
AbstractObjectivesThe primary objective was to compare the differences in clinical efficacy of the starting dose of Ritalin® LA…
Summary Stimulant therapy is the mainstay of treatment for children, adolescents and adults with attention-deficit/hyperactivity…
The treatment of substance-abusing adolescents who have comorbid attention-deficit/hyperactivity disorder (ADHD) involves the…